Boston Scientific secures FDA approval for Precision Montage SCS System

19 May 2016 (Last Updated May 19th, 2016 18:30)

The US Food and Drug Administration (FDA) has granted approval to Boston Scientifics' Precision Montage MRI spinal cord stimulator (SCS) System.

The US Food and Drug Administration (FDA) has granted approval to Boston Scientifics' Precision Montage MRI spinal cord stimulator (SCS) System.

The precision Montage System is designed to relieve patients afflicted with chronic pain by offering full-body magnetic resonance imaging (MRI) in a 1.5 Tesla environment.

Chronic pain affects more than 100 million Americans, debilitating their quality of life. Such chronic pain can shift its occurrence, and change in its type and intensity.

"With the approval of the Precision Montage MRI SCS System, more of my patients can benefit from this powerful technology."

The system leverages on the MultiWave Technology which delivers a series of waveforms with higher rates designed to respond to any fluctuations in pain over time.

The waveforms are facilitated by Boston Scientific's Illumina 3D algorithm which is a three-dimensional, anatomy-driven computer model which allows a point-and-click pain target to assist in the chronic pain treatment.

The wave forms can be tailored to suit the therapeutic process intended for patients facilitating pain relief.

The Avista MRI Lead features a heat canceling technology to ensure safety while issuing the full-body MRI Scans. The layers of the lead are designed to work in tandem to erase radio frequency (RF) waves emitting heat.

Such construction intends to allow optimal steering and durability.

University Hospital Case Medical Center, Cleveland, Ohio anesthesiology pain medicine programme director Salim Hayek said: "The Boston Scientific Illumina 3D portfolio allows me to tailor therapy for each patient consistently and effectively.

"With the approval of the Precision Montage MRI SCS System, more of my patients can benefit from this powerful technology since they can now have access to future MRI scan needs."